Archives

by in
Entry Author Date Location
With IPO Expectations Reset (Again), Vital Therapies Begins Trading 04/17/14 San Diego
San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More 04/11/14 San Diego
San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More 12/06/13 San Diego
San Diego Life Sciences Roundup: IPOs, CareFusion, and More 11/22/13 San Diego
San Diego Life Sciences Roundup: IPOs, Illumina, KFx Medical, & More 10/17/13 San Diego
San Diego Life Sciences Roundup: Illumina, Conatus, Isis, and More 07/25/13 San Diego
San Diego’s Conatus Pharmaceuticals Sets Price Range for IPO Shares 07/09/13 San Diego
Conatus Pharmaceuticals Files for $69M IPO to Advance Liver Drugs 06/17/13 San Diego
San Diego Life Sciences Roundup: Arena, Organovo, Isis, & More 06/13/13 San Diego
Lumena Raises $23 Million to Advance Drug for Rare Liver Diseases 05/08/13 San Diego
San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More 04/25/13 San Diego
San Diego Life Sciences Roundup: Halozyme, Acadia, Trovagene, & More 03/29/13 San Diego
San Diego Life Sciences Roundup: Allergan, Qualcomm Life, & More 11/21/12 San Diego
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News 06/30/11 San Diego
Conatus Raises $20M for Hepatitis C Studies 02/14/11 San Diego
Ligand Licenses Liver Drug Candidates 01/06/11 San Diego
Conatus Gets Pfizer Subsidiary 08/02/10 San Diego
FDA Approves Over-the-Counter Version of Santarus Drug, Pioneer of Algal Biofuels Says Algae Will Make Drugs Too, Receptos Gets $25M, & More San Diego Life Sciences News 12/02/09 San Diego
Ocera Therapeutics, Pursuing New Drug for Liver, Hopes to Help People Stay Mentally Sharp 11/25/09 San Diego
Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients 11/01/08 Boston
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds 11/01/08 San Diego
Page 1 of 1